EBP week 5
docx
keyboard_arrow_up
School
Purdue University *
*We aren’t endorsed by this school
Course
1903A
Subject
Medicine
Date
Dec 6, 2023
Type
docx
Pages
2
Uploaded by DukeKnowledgeDeer6
Hospital readmission rates are being used as quality indicators by CMS and are publicly tied to hospital
reimbursements. Preventable readmissions cost $12 billion annually and are a burden on patients,
families, and the healthcare system, and can disrupt a patient's disease course. Reducing readmissions
can improve patient satisfaction and quality of life.
Not surprisingly, medical complexity is a recurring theme in the literature regarding postsurgical
morbidity, mortality, and readmission. Looking at medical readmission to pediatric hospitals.
Developed in 2000, the Pediatric Complex Chronic Conditions Classification System is a comprehensive
set of ICD-10 codes and CPT codes. The working definition of a CCC is any medical condition that can be
reasonably expected to last at least 12 months (unless death intervenes) and to involve either several
different organ systems or 1 system severely enough to require specialty pediatric care and probably
some period of hospitalization in a tertiary care center.22 Children with CCCs are thought to make up
2.9% of the pediatric patient population but account for 18.8% of admissions, 23.4% of bed-days, and
23.2% ($3.42 billion) of aggregate charges.20
Vo, Zurakowski, D., Faraoni, D., & Veyckemans, F. (2018). Incidence and
predictors of 30
‐
day postoperative readmission in children.
Pediatric
Anesthesia
,
28
(1), 63–70.
https://doi.org/10.1111/pan.13290
https://chamberlain.primo.exlibrisgroup.com/permalink/01CUCON_INST/f6kb8f/cdi_proquest_miscellan
eous_1966981900
Describe one key feature of design that compares effectiveness.
New research designs have emerged specifically in response to the need to provide evidence for
practice. These studies seek to compare the effectiveness of a set of interventions with the effectiveness
of alternative or traditional practices. Comparative effectiveness studies, sometimes called pragmatic
randomized controlled trials, assess competing interventions for efficacy, cost, and usefulness to specific
populations. Such studies have many of the characteristics of randomized controlled trials but are
adapted to allow for a more naturalistic approach, a shorter timeline, and easier translation into
practice. Comparative effectiveness trials are often integrated seamlessly into usual clinical care and
participants’ lives, with a desired outcome of determining whether one treatment is better than another
in the same population (Marquis-Gravel et al., 2021).
Comparative effectiveness research emerged in response to the necessity of answering real-world
questions in settings in which a range of possible options are available, and the best choice may vary
across patients, settings, and time (Armstrong, 2012).
Evidence is generated using both experimental and observational methods. Synthesis of the evidence
uses systematic reviews, decision modeling, and cost-effectiveness analysis to draw conclusions.
Evidence is generated using both experimental and observational methods. Synthesis of the evidence
uses systematic reviews, decision modeling, and cost-effectiveness analysis to draw conclusions.
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help